JEREMY PETZOLD: Open Payments
NPI 1962090845 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 16 payments from 9 companies in 2025. Trend: 2023 $329 · 2024 $2,214 · 2025 $482
Food & beverage: $297Education: $185
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $142 |
| PFIZER INC. | 2 | $105 |
| Merck Sharp & Dohme LLC | 2 | $61 |
| ABBVIE INC. | 3 | $56 |
| Ferring Pharmaceuticals Inc. | 2 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Teleflex LLC | 1 | $19 |
| Calyxo, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Xtandi, ADSTILADRIN, LUPRON DEPOT, KEYTRUDA QLEX, KEYTRUDA, BOTOX, JOURNAVX, BARRIGEL.
Industry payments across MI — which companies pay providers there.
